<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Biel A</submitter><funding>National Institute of Neurological Disorders and Stroke</funding><funding>NINDS NIH HHS</funding><pagination>858582</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9008325</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15</volume><pubmed_abstract>AUTS2 syndrome is a genetic disorder that causes intellectual disability, microcephaly, and other phenotypes. Syndrome severity is worse when mutations involve 3' regions (exons 9-19) of the &lt;i>AUTS2&lt;/i> gene. Human AUTS2 protein has two major isoforms, full-length (1259 aa) and C-terminal (711 aa), the latter produced from an alternative transcription start site in exon 9. Structurally, AUTS2 contains the putative "AUTS2 domain" (∼200 aa) conserved among AUTS2 and its ohnologs, fibrosin, and fibrosin-like-1. Also, AUTS2 contains extensive low-complexity sequences and intrinsically disordered regions, features typical of RNA-binding proteins. During development, &lt;i>AUTS2&lt;/i> is expressed by specific progenitor cell and neuron types, including pyramidal neurons and Purkinje cells. AUTS2 loc</pubmed_abstract><journal>Frontiers in molecular neuroscience</journal><pubmed_title>AUTS2 Syndrome: Molecular Mechanisms and Model Systems.</pubmed_title><pmcid>PMC9008325</pmcid><funding_grant_id>R01 NS092339</funding_grant_id><pubmed_authors>Castanza AS</pubmed_authors><pubmed_authors>Hester ME</pubmed_authors><pubmed_authors>Wester JC</pubmed_authors><pubmed_authors>Biel A</pubmed_authors><pubmed_authors>Chifamba L</pubmed_authors><pubmed_authors>Rutherford R</pubmed_authors><pubmed_authors>Fair SR</pubmed_authors><pubmed_authors>Hevner RF</pubmed_authors></additional><is_claimable>false</is_claimable><name>AUTS2 Syndrome: Molecular Mechanisms and Model Systems.</name><description>AUTS2 syndrome is a genetic disorder that causes intellectual disability, microcephaly, and other phenotypes. Syndrome severity is worse when mutations involve 3' regions (exons 9-19) of the &lt;i>AUTS2&lt;/i> gene. Human AUTS2 protein has two major isoforms, full-length (1259 aa) and C-terminal (711 aa), the latter produced from an alternative transcription start site in exon 9. Structurally, AUTS2 contains the putative "AUTS2 domain" (∼200 aa) conserved among AUTS2 and its ohnologs, fibrosin, and fibrosin-like-1. Also, AUTS2 contains extensive low-complexity sequences and intrinsically disordered regions, features typical of RNA-binding proteins. During development, &lt;i>AUTS2&lt;/i> is expressed by specific progenitor cell and neuron types, including pyramidal neurons and Purkinje cells. AUTS2 loc</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-19T16:20:32.22Z</modification><creation>2025-02-19T01:07:09.104Z</creation></dates><accession>S-EPMC9008325</accession><cross_references><pubmed>35431798</pubmed><doi>10.3389/fnmol.2022.858582</doi></cross_references></HashMap>